These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 214541

  • 1. Mesoionic xanthine analogs as inhibitors of cyclic AMP phosphodiesterase.
    Glennon RA, Rogers ME, Bass RG, Ryan SB.
    J Pharm Sci; 1978 Dec; 67(12):1762-5. PubMed ID: 214541
    [Abstract] [Full Text] [Related]

  • 2. Benz-fused mesoionic xanthine analogues as inhibitors of cyclic-AMP phosphodiesterase.
    Glennon RA, Gaines JJ, Rogers ME.
    J Med Chem; 1981 Jun; 24(6):766-9. PubMed ID: 6265639
    [No Abstract] [Full Text] [Related]

  • 3. Mesoionic xanthine analogues: phosphodiesterase inhibitory and hypotensive activity.
    Glennon RA, Rogers ME, Smith JD, El-Said MK, Egle JL.
    J Med Chem; 1981 Jun; 24(6):658-61. PubMed ID: 6265635
    [Abstract] [Full Text] [Related]

  • 4. Correlation of biological activities of mesoionic and benz-fused mesoionic xanthine analogs with van der Waals volume and molecular connectivity.
    Prabhakar YS, Handa A, Gupta SP.
    J Pharmacobiodyn; 1984 Jun; 7(6):366-71. PubMed ID: 6090634
    [Abstract] [Full Text] [Related]

  • 5. PDE4 inhibitors: new xanthine analogues.
    Montana JG, Cooper N, Dyke HJ, Gowers L, Gregory JP, Hellewell PG, Miotla J, Morris K, Naylor R, Tuladhar B, Warneck JB.
    Bioorg Med Chem Lett; 1998 Oct 20; 8(20):2925-30. PubMed ID: 9873649
    [Abstract] [Full Text] [Related]

  • 6. Methylxanthine inhibitors of phosphodiesterases.
    Wells JN, Miller JR.
    Methods Enzymol; 1988 Oct 20; 159():489-96. PubMed ID: 2457788
    [No Abstract] [Full Text] [Related]

  • 7. Mesoionic purinone analogues as inhibitors of cyclic-AMP phosphodiesterase: a comparison of several ring systems.
    Rogers ME, Glennon RA, Smith JD, Boots MR, Nanavati N, Maconaughey E, Aub D, Thomas S, Bass RG, Mbagwu G.
    J Med Chem; 1981 Nov 20; 24(11):1284-7. PubMed ID: 6273558
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of beef cortex membrane-bound 3', 5'-AMP phosphodiesterase by halogenated purines.
    Macdonald IA.
    Pharmacol Res Commun; 1977 Jan 20; 9(1):49-58. PubMed ID: 194263
    [No Abstract] [Full Text] [Related]

  • 9. Tissue selective inhibition of cyclic nucleotide phosphodiesterase by denbufylline.
    Wilke R, Arch JR, Nicholson CD.
    Arzneimittelforschung; 1989 Jun 20; 39(6):665-7. PubMed ID: 2476135
    [Abstract] [Full Text] [Related]

  • 10. Relaxant effects of various xanthine derivatives. Relationship to cyclic nucleotide phosphodiesterase inhibition.
    Takagi K, Ogawa K, Tanaka H, Satake T, Watanabe Y, Chijiwa T, Hidaka H.
    Adv Second Messenger Phosphoprotein Res; 1992 Jun 20; 25():353-62. PubMed ID: 1313267
    [No Abstract] [Full Text] [Related]

  • 11. Theophylline-like properties of xanthine analogs.
    Levallois C, Bonnafous JC, Francoise MA, Sablayrolles C, Chapat JP, Mani JC.
    Biochem Pharmacol; 1984 Jul 15; 33(14):2253-7. PubMed ID: 6087821
    [Abstract] [Full Text] [Related]

  • 12. Selective inhibition of cyclic nucleotide phosphodiesterases by analogues of 1-methyl-3-isobutylxanthine.
    Kramer GL, Garst JE, Mitchel SS, Wells JN.
    Biochemistry; 1977 Jul 26; 16(15):3316-21. PubMed ID: 196632
    [No Abstract] [Full Text] [Related]

  • 13. Effect of some phosphodiesterase inhibitors on two different preparations of adenosine 3',5'-monophosphate phosphodiesterase.
    Du Moulin A, Schultz J.
    Experientia; 1975 Aug 15; 31(8):883-4. PubMed ID: 169139
    [No Abstract] [Full Text] [Related]

  • 14. Mesoionic xanthine analogues: antagonists of adenosine receptors.
    Glennon RA, Tejani-Butt SM, Padgett W, Daly JW.
    J Med Chem; 1984 Oct 15; 27(10):1364-7. PubMed ID: 6090665
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of separated forms of cyclic nucleotide phosphodiesterase from pig coronary arteries by 1,3-disubstituted and 1,3,8-trisubstituted xanthines.
    Wells JN, Garst JE, Kramer GL.
    J Med Chem; 1981 Aug 15; 24(8):954-8. PubMed ID: 6276544
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of fibroblast cyclic AMP escape and cyclic nucleotide phosphodiesterase activities by xanthines.
    Nemecek GM, Wells JN, Butcher RW.
    Mol Pharmacol; 1980 Jul 15; 18(1):57-64. PubMed ID: 6251359
    [No Abstract] [Full Text] [Related]

  • 17. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
    Miot F, Erneux C, Wells JN, Dumont JE.
    Mol Pharmacol; 1984 Mar 15; 25(2):261-6. PubMed ID: 6321949
    [Abstract] [Full Text] [Related]

  • 18. Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity.
    Semmler J, Gebert U, Eisenhut T, Moeller J, Schönharting MM, Alléra A, Endres S.
    Immunology; 1993 Apr 15; 78(4):520-5. PubMed ID: 8388363
    [Abstract] [Full Text] [Related]

  • 19. Interaction of four methylxanthine compounds and norepinephrine on cardiac phosphorylase activation and cardiac contractility.
    McNeill JH, Brenner MJ, Muschek LD.
    Recent Adv Stud Cardiac Struct Metab; 1973 Apr 15; 3():261-73. PubMed ID: 4377599
    [No Abstract] [Full Text] [Related]

  • 20. Effects of alkyl substitutions of xanthine skeleton on bronchodilation.
    Sakai R, Konno K, Yamamoto Y, Sanae F, Takagi K, Hasegawa T, Iwasaki N, Kakiuchi M, Kato H, Miyamoto K.
    J Med Chem; 1992 Oct 30; 35(22):4039-44. PubMed ID: 1331453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.